Company Overview
About Algen Biotechnologies
Algen Biotechnologies is a San Francisco-based drug discovery company that builds computational platforms to decode functional gene networks — using machine learning and genomic data to map the relationships between genes, understand how gene interactions drive disease, and identify novel therapeutic targets that traditional drug discovery approaches miss because they analyze genes in isolation. Founded in 2018 by Chun Hao Huang and Christine Du and a Y Combinator W20 graduate, Algen raised $12.63 million total including a $9 million Seed VC-II round led by Viking Global Investors in February 2022.
Business Model & Competitive Advantage
Algen's platform addresses a fundamental limitation in genomics-based drug discovery: most genetic analysis identifies individual disease-associated genes, but biology operates through networks — a gene's functional impact depends on which other genes it interacts with, which pathways are co-activated, and the cellular context. Algen's functional genomics platform maps these network relationships from large-scale genetic perturbation data, identifying which gene combinations drive disease phenotypes and which targets are central to therapeutic intervention.
Competitive Landscape 2025–2026
In 2025, Algen Biotechnologies competes in the AI drug discovery and computational genomics space with Recursion Pharmaceuticals (RXRX, AI-driven drug discovery), Schrödinger (computational chemistry and biology), Insitro, and academic-spinout gene network platforms for computational drug target identification. The AI drug discovery space has attracted significant investment — Recursion went public, Isomorphic Labs (DeepMind spinout) signed major pharma deals — validating the thesis that computational approaches can accelerate target identification and candidate selection. Viking Global's investment reflects institutional conviction in Algen's gene network approach. The 2025 strategy focuses on advancing lead therapeutic programs from the computational platform into experimental validation, building pharma partnerships for target licensing, and growing the platform's applicability across oncology, neurodegeneration, and metabolic disease.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Algen Biotechnologies is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Not So Random Others
Yoneda Labs
Yoneda Labs is a San Francisco-based AI company applying foundation models to automate chemical reaction optimization for drug discovery and pharmaceutical process development — providing chemists wit
Decoda Health
Decoda Health is a San Francisco-based AI healthcare administration platform — backed by Y Combinator (S23) with $4.5 million raised from YC, Amino Capital, Bossa Nova Ventures, Cadenza Ventures, Grap
Fortuna Health
Fortuna Health is a New York City-based healthcare technology company — backed by Y Combinator with $22 million in total funding including an $18 million Series A in July 2025 led by Andreessen Horowi
Brisk
Brisk is a functional beverage brand offering ready-to-drink iced tea and juice drinks, jointly owned by PepsiCo and Unilever under the Lipton brand partnership. Launched in the 1990s, Brisk positione
Altria
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and s
AbbVie
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Sp
Compare Algen Biotechnologies with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Algen Biotechnologies? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Algen Biotechnologies Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Algen Biotechnologies vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →